Details
Category: Volume 08 Issue 02 February 2020
Hits: 1031

Title: Serum Gamma Glutamyl Transferase is a Potential Biomarker for Isolated Systolic Hypertension

Authors: Ritu Sharma, Mridula Mahajan

 DOI: https://dx.doi.org/10.18535/jmscr/v8i2.162

Abstract

   

Background: Oxidative stress plays a key role in the development of Isolated systolic hypertension (ISH) commonly associated with type2 diabetes mellitus. Gamma glutamyl transferase (GGT) enzyme maintains the GSH-cysteine homeostasis and detoxifies whereas magnesium maintains glucose homeostasis and hence both these molecules lowers oxidative stress.

Objectives: The aim of the present study was to elucidate the relationship of serum GGT and magnesium with isolated systolic hypertension associated with type 2 diabetes mellitus.

Methods: 60 diagnosed cases of type 2 diabetes mellitus were segregated into two Groups: Group1 comprised patients having uncontrolled ISH and Group2 included patients with controlled generalized hypertension. Control group (n=40) comprised of non-diabetic subjects divided on the basis of presence or absence of ISH. Serum lipid profile, GGT, magnesium, albumin and fasting blood glucose were estimated. Data was statistically analyzed using t-test and chi-square. P<0.05 was considered as statistically significant.

Results: Serum GGT activity was markedly high (p<0.05) in type2 diabetic patients having ISH (Group 1) as compared to Group 2 patients while serum magnesium and albumin levels did not differ significantly (p>0.05). Similar results were also observed in control group. Serum Mg and albumin levels were low in type2 diabetic patients as compared to control group with or without ISH. A significant positive correlation (p<0.05) was observed between increased GGT and systolic blood pressure in both patient and control subjects. Lipid profile of patients and control group did not show significant difference.

Conclusions: Serum GGT may act as potential biomarker for isolated systolic hypertension and can be used for its diagnosis and prognosis.

Keywords: Type 2 Diabetes mellitus, isolated systolic hypertension, oxidative stress, gamma glutamyl transferase, magnesium.

References

  1. Paolicchi A, Minolti G, Tonarelli P, Tongiani R, Decesare D, Mezzetti A, et al. Gamma gltamyl transpeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 1999; 47:151-60
  2. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma glutamyl transpeptidase enzyme activity. Circulation. 2004; 109:1440
  3. Gyung KJ, Kiyuk C, Eun HOC, Jong-Min L, Ki-Bac S. Serum gamma-glutamyl transferase is a predictor of mortality in patients with acute myocardial infarction. Medicine. 2018; 97: e11393
  4. Onat A, Can G, Ornak E, Cicek G, Ayhan E, Dogan Y, et al. Serum gamma glutamyltransferase:independent predictor of risk of diabetes, hypertension, metabolic syndrome and coronary disease. Obesity 2012;20:842-848
  5. DEmircan S, Yazici M, Durna K, Kilicaslan F, Demir S, Piner M, Gulel O, et al. The importance of gamma glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol.2009;32:220-225
  6. Ko SH, Baeg MK, Han KD, Ko SH, Ahn YB. Increased liver markers are associated with higher risk of type 2 diabetes. World J Gastroenterol 2015; 21:7478-7487
  7. Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999;13 :233-244
  8. Moore TJ, Conlin PR, Ard J. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension 2001;38: 155–158.
  9. Kumar P, Bhargava S, Agarwal PK, Garg A, Khosla A. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy. J Family Med and Primary Care.2019; 8: 1671-1677
  10. Krasimir Kostov. Effects of Magnesium deficiency on mechanisms of insulin resistance in type2 diabetes. Int.J.Mol.Sc. 2019; 20:1351
  11. Saris NE, Mervaola E, Karppanen H, Khawaza JA, Lewenstam A. Magnesium: An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294(1-2):1-26
  12. Olatunji LA, Soladoye AO. Effect of increased magnesium intake on plasma cholesterol, triglycerides and oxidative stress in alloxan diabetic rats. Afr J Med Sci 2007;36 :155-161
  13. Rao PP, Shariff MG. Serum magnesium levels in type2 diabetic patients with microalbuminuria and normoalbuminuria. Int J Sci Stud 2015;3 :11—15
  14. Sen N, Ozlu MF, Basar N, Ozcan F, Gungor O, Turak O, et al. Relationship between elevated serum gamma glutamyltransferase activity and slow coronary flow. Turk Kardiyol Dern Ars 2009;37 :168-173
  15. Gohel MG, Chacko AN. Serum GGT activity and hsCRP levels in patients with type2 diabetes mellitus with good and poor glycemic control: An evidence linking oxidative stress, inflammation and glycemic control. J Diab and Metab disorders 2013;12:56
  16. Knubchavhandani A, Parmer VS, Gandhi P, Sanghai H, Sendhav S, Patel J. The study of correlation between serum GGT and type2 diabetes mellitus. JARBS 2014;6:18-20
  17. Lee DS, Evan JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyltransferase and metabolic syndrome, cardiovascular disease, and mortality risk: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127-133
  18. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Cur Op Clin Nut Metab Care 2002;5 :561-568
  19. Robertson RP, Harmon J. Beta cell glucose toxicity, lipotoxicity and chronic oxidative stress in type 2 diabetes. Diabetes 2004;53(supple 1):119-124
  20. Dan S,Banerjee I, Roy H, Roy S, Jana T, Dan S.  Association between serum gamma glutamyl transferase level and hypertension in Indian Adults: A population based cross-sectional study. N Am J Med Sci 2012; 4: 496–498
  21. Dong JY, Xun P, He KA, Qin LQ. Magnesium intake and risk of type2 diabetes. Diab care 2011; 34 :2116-2122
  22. McCarty MF. Magnesium may mediate the favourabe impact of whole grains on insulin sensitivity by acting as mild calcium antagonist. Med Hypothesis 2005;64 :619-627
  23. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR, et al. Magnesium intake in relation to systemic inflammation, insulin resistance and the incidence of diabetes. Diabetes Care.2010;33 :2604-2610.

Corresponding Author

Dr Ritu Sharma

Assistant Professor, Department of Biochemistry, Govt. Medical College, Amritsar-143001, Punjab-India